Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mellitus experience hypoglycaemia and the strategies they use to control it. Methods: Using a three-step search strategy, all published and unpublished qualitative studies in English from January 2000 to August 2010 were retrieved. Participants diagnosed with type 1 or type 2 diabetes mellitus, experienced in self-managing their hypoglycaemia, and who lived independently in the community and attended primary care or outpatient clinics were included. An initial limited search was conducted in MEDLINE and CINAHL to identify keywords and index terms, which were then used in a second search across the CINAHL, PUBMED, SCOPUS, PsycINFO, PsycARTICLES, ...
BACKGROUND: In people with type 1 diabetes (T1D), nocturnal hypoglycaemia (NH) can be slept through ...
Hypoglycaemia is a common barrier to optimal glycaemic management and often feared among adults with...
Abstract Hypoglycemia is common in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) and...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Aim To summarize and critically appraise the recent qualitative evidence regarding the impact of hyp...
Objective Hypoglycaemic episodes and fear of hypoglycaemia can be burdensome for adults with type 1 ...
Background: Hypoglycemia unawareness (HU) has been attributed to both a downward shift in central ne...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
Objectives: Hypoglycemia is a common adverse event for people with type 1 and type 2 diabetes mellit...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: In people with type 1 diabetes (T1D), nocturnal hypoglycaemia (NH) can be slept through ...
Hypoglycaemia is a common barrier to optimal glycaemic management and often feared among adults with...
Abstract Hypoglycemia is common in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) and...
Aim: To synthesise the evidence on how community-dwelling adults with type 1 and type 2 diabetes mel...
Aim: To synthesise the evidence on how community‐dwelling adults with type 1 and type 2 diabetes mel...
BACKGROUND: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to infl...
Background: Hypoglycaemia, a common complication of diabetes drug therapy, has been reported to inf...
Aims: Despite improvements in insulin therapy, hypoglycaemia remains an inevitable part of life for...
Aims: To describe adults’ experiences of hypoglycaemia in diabetes mellitus, and the consequences of...
Aim To summarize and critically appraise the recent qualitative evidence regarding the impact of hyp...
Objective Hypoglycaemic episodes and fear of hypoglycaemia can be burdensome for adults with type 1 ...
Background: Hypoglycemia unawareness (HU) has been attributed to both a downward shift in central ne...
Abstract Background Hypoglycaemia is a common and potentially avoidable adverse event in people with...
Objectives: Hypoglycemia is a common adverse event for people with type 1 and type 2 diabetes mellit...
BACKGROUND: Hypoglycaemia is a common and potentially avoidable adverse event in people with type 2 ...
BACKGROUND: In people with type 1 diabetes (T1D), nocturnal hypoglycaemia (NH) can be slept through ...
Hypoglycaemia is a common barrier to optimal glycaemic management and often feared among adults with...
Abstract Hypoglycemia is common in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) and...